Press releaseGlobe Newswire
Immuneering
IMRX · NASDAQ
$3.73+$0.07 (+1.91%)TodayMarket closed ·
Prev close $3.66
Latest news
- Press releaseGlobe Newswire
Immuneering Presents Data at 2026 AACR Conference on Pancreatic Cancer Supporting Atebimetinib’s Mechanisms Designed to Extend Survival in Pancreatic Cancer
- Press releaseGlobe Newswire
Immuneering to Present at the ESMO Congress 2026
- Press releaseGlobe Newswire
Immuneering to Present at the AACR Conference on Pancreatic Cancer, Highlighting Atebimetinib’s Dual Mechanism for Extended Survival
- Press releaseGlobe Newswire
Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients
- Press releaseGlobe Newswire
Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates
- Press releaseGlobe Newswire
Publication in Cancer Research Details Atebimetinib’s Broad, Durable Preclinical Activity and Favorable Tolerability Across RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition
- Press releaseGlobe Newswire
Immuneering Corporation Announces Grants of Inducement Awards
- Press releaseGlobe Newswire
Immuneering Appoints Andrew Gengos as Chief Financial Officer
- Press releaseGlobe Newswire
Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer
- NewsAvi Kapoor
Crude Oil Edges Higher; US Consumer Sentiment Falls In May
- News
Benzinga Bulls And Bears: Chevron, Palantir, Aquestive — And Real Estate Stocks Plummet
- NewsAvi Kapoor
Dow Jumps Over 250 Points; US Initial Jobless Claims Increase
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Nasdaq Falls Over 100 Points; Acuity Posts Upbeat Earnings
- NewsRishabh Mishra
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Drop— AZZ, Northrop Grumman, Immuneering In Focus (UPDATED)
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Why AZZ Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday
- NewsAvi Kapoor
Dynavax Technologies, Omeros, Agios Pharmaceuticals, Nike And Other Big Stocks Moving Higher On Wednesday
- Press releasePRNewswire
Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
- Press releaseGlobe Newswire
Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B
- Press releaseGlobe Newswire
Immuneering Reports Third Quarter 2025 Financial Results and Provides Business and Clinical Updates
- News
Earnings Scheduled For November 12, 2025
- News
A Preview Of Immuneering's Earnings
- Press releasePRNewswire
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up
- Press releasePRNewswire
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releasePRNewswire
How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options
- NewsChris Katje
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
- NewsAvi Kapoor
Nasdaq Surges 1%; Meta Posts Upbeat Earnings
- NewsAvi Kapoor
Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
- News
Market-Moving News for August 1st
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.